Physician

Asif Ali Khan Ansari, MD

According to 2025 Medicare claims, Asif Ansari, MD (NPI: 1528299872) practices nephrology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is PERMIAN BASIN KIDNEY CENTER INC (NPI: 1285199026; TIN: 813411343) and primary practice location at 79706-2807. Ansari is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 695 traditional Medicare patients, billed 5,235 HCPCS/CPT codes, and received $417,026 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,436 prescription claims across 591 beneficiaries totaling $673,366 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2022 DME data shows 11 claims. Open Payments data shows 43 records totaling $827. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $192,893 to $417,026. Similarly, Part D prescription costs have risen steadily, from $69,130 to $673,366. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	708	3,410	$192,893
2016	749	3,413	$245,866
2017	866	4,213	$373,283
2018	818	3,733	$358,825
2019	725	3,258	$351,651
2020	826	4,991	$538,625
2021	848	5,366	$614,914
2022	827	4,995	$532,610
2023	740	4,589	$449,463
2024	695	5,235	$417,026

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	1,201	$69,130
2016	268	1,828	$115,393
2017	326	2,431	$222,696
2018	358	2,796	$292,878
2019	384	2,801	$456,357
2020	421	3,258	$631,477
2021	448	2,782	$604,604
2022	495	3,221	$518,662
2023	516	3,387	$711,994
2024	591	4,436	$673,366

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	43	$1,305
2017	N/R	74	$2,852
2018	N/R	11	$189
2019	N/R	129	$4,014
2020	N/R	162	$7,499
2021	N/R	90	$4,148
2022	N/R	11	$190
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	192	260	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	265	541	$77
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	280	1,290	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	150	186	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	289	570	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	39	1,290	$121,383
Rayaldee	Calcifediol	65	1,950	$88,404
Auryxia	Ferric Citrate	32	1,140	$67,883
Farxiga	Dapagliflozin Propanediol	61	2,430	$44,295
Jardiance	Empagliflozin	39	1,500	$29,844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$827	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asif Ali Khan Ansari, MD?

Tedicare shows public-source Medicare data for Asif Ali Khan Ansari, MD (NPI 1528299872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asif Ali Khan Ansari, MD have ACO affiliation data?

Asif Ali Khan Ansari, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Asif Ali Khan Ansari, MD?

Asif Ali Khan Ansari, MD is linked to PERMIAN BASIN KIDNEY CENTER INC (billing NPI 1285199026) in the available physician profile data.

Does Asif Ali Khan Ansari, MD have Open Payments data?

Asif Ali Khan Ansari, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.